Palvella Therapeutics (PVLA) EPS (Weighted Average and Diluted) (2020 - 2024)
Historic EPS (Weighted Average and Diluted) for Palvella Therapeutics (PVLA) over the last 5 years, with Q4 2024 value amounting to $0.12.
- Palvella Therapeutics' EPS (Weighted Average and Diluted) fell 9941.46% to $0.12 in Q4 2024 from the same period last year, while for Dec 2024 it was -$7.83, marking a year-over-year decrease of 15124.35%. This contributed to the annual value of -$7.83 for FY2024, which is 46082.95% down from last year.
- Latest data reveals that Palvella Therapeutics reported EPS (Weighted Average and Diluted) of $0.12 as of Q4 2024, which was down 9941.46% from -$3.94 recorded in Q3 2024.
- Palvella Therapeutics' 5-year EPS (Weighted Average and Diluted) high stood at $20.5 for Q4 2023, and its period low was -$8.7 during Q3 2023.
- In the last 5 years, Palvella Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$0.22 in 2021 and averaged $0.37.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 20078.35% in 2021, then skyrocketed by 268571.43% in 2023.
- Quarter analysis of 5 years shows Palvella Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.26 in 2020, then soared by 34.42% to -$0.17 in 2021, then grew by 17.89% to -$0.14 in 2022, then skyrocketed by 14742.86% to $20.5 in 2023, then tumbled by 99.41% to $0.12 in 2024.
- Its last three reported values are $0.12 in Q4 2024, -$3.94 for Q3 2024, and -$2.47 during Q2 2024.